Roboz GJ, Yee K, Verma A, Borthakur G, et al. Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes. Leuk Lymphoma 2021 Dec 19:1-5. doi: 10.1080/10428194.2021.2012667.
PMID: 34927529